Compare
RetinalGenix Technologies Inc. vs ALR Technologies SG Ltd. vs Stimcell Energetics Inc. vs Odyssey Health, Inc.
| Latest fiscal year | RetinalGenix Technologies Inc. RTGN | ALR Technologies SG Ltd. ALRTF | Stimcell Energetics Inc. STME | Odyssey Health, Inc. ODYY |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-05-31 | 2026-07-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | -$2.43M | -$22.06M | -$895.4K | -$5.73M |
| EPS (Diluted) | -$0.13 | -$0.04 | n/a | -$0.05 |
| Operating cash flow | -$558.4K | -$1.87M | -$312.1K | -$1.05M |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | n/a | n/a | n/a | n/a |
| Total assets | $21.0K | $47.4K | $81.5K | $147.9K |
| Total liabilities | $2.32M | $39.91M | $1.89M | n/a |
| Shareholders' equity | -$2.30M | -$39.86M | -$1.81M | -$12.13M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | 18.75M | n/a | n/a | 105.97M |
Revenue, most recent five fiscal years
| Fiscal year | RetinalGenix Technologies Inc. | ALR Technologies SG Ltd. | Stimcell Energetics Inc. | Odyssey Health, Inc. |
|---|---|---|---|---|
| Latest | n/a | $25.5K Ended 2023-12-31 | $0 Ended 2024-05-31 | $0 Ended 2020-07-31 |
| 1 year earlier | n/a | $2.4K Ended 2022-12-31 | $2.8K Ended 2023-05-31 | $0 Ended 2019-07-31 |
| 2 years earlier | n/a | $7.5K Ended 2021-12-31 | n/a | $0 Ended 2018-07-31 |
| 3 years earlier | n/a | n/a | n/a | $0 Ended 2017-07-31 |
| 4 years earlier | n/a | n/a | $95.8K Ended 2020-05-31 | $37.5K Ended 2016-07-31 |